T cell receptors and peptides derived by mutations for the treatment of cancer

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP15162015.0

公开号：

EP3075389A1

申请日:

2015.03.31

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention relates to a method for providing a neopeptide-specific T cell, wherein the neopeptide-specific T cell forms a complex having a half-life (T1/2) of at least 50 s with a neopeptide-MHC monomer. The present invention further relates to a T cell obtainable by the method as well as a pharmaceutical composition comprising such T cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/